Roth Capital Starts Neurocrine Bio. (NBIX) at Buy
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $140.71 -0.8%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 12 | New: 74
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 12 | New: 74
Join SI Premium – FREE
Roth Capital initiates coverage on Neurocrine Bio. (NASDAQ: NBIX) with a Buy. PT $14.00.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $7.38 yesterday.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $7.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine to present Vykat XR and PWS research at FPWR conference
- Wells Fargo Starts Hamilton Lane Inc. (HLNE) at Overweight
- Neurocrine Biosciences names returning CMO, parts ways with Keswani
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
